DDB2 was shown to act as a haploinsufficient tumor suppressor [39], but to complicate the issue further, DDB2 is expressed at higher levels in estrogen receptor positive breast cancer cells, and its knockdown negatively impacts the growth rate of these cells [40]. The gene discussed is ESR1; the disease is breast cancer.